Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.98
-0.06 (-0.60%)
At close: Dec 15, 2025, 4:00 PM EST
9.98
0.00 (0.00%)
After-hours: Dec 15, 2025, 5:27 PM EST
Immatics Market Cap
Immatics has a market cap or net worth of $1.21 billion as of December 15, 2025. Its market cap has increased by 30.32% in one year.
Market Cap
1.21B
Enterprise Value
722.67M
1-Year Change
30.32%
Ranking
Category
Stock Price
$9.98
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.21B, an increase of 603.31%. That is a compound annual growth rate of 32.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 1.22B | 43.82% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | 678.78M | 263.23% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |